Jasper Therapeutics JSPR Income Statement (2019-2025)

NASDAQ JSPR
$0.69 -0.06 (-8.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Shares Outstanding (Entity) (Quarter)
1.00M1.00M0.50M1.14M3.79M3.80M3.80M3.80M8.82M11.08M11.08M11.16M15.09M15.11M15.00M15.02M15.02M16.22M16.64M19.17M
Operating items
Research & Development (Quarter)
4.42M5.16M7.19M8.66M8.19M8.13M9.02M0.84M9.80M13.30M14.85M13.84M10.30M11.30M14.46M19.77M16.16M21.20M14.39M11.36M
Selling, General & Administrative (Quarter)
1.83M3.26M2.89M3.42M4.59M3.83M3.69M4.46M4.14M4.53M4.51M3.89M4.77M4.70M5.43M5.51M5.64M5.88M4.78M4.48M
Restructuring Costs (Quarter)
0.13M0.13M0.08M0.10M0.56M0.48M0.47M6.11M6.21M9.76M15.77M
Other Operating Expenses (Quarter)
-0.13M-0.13M-0.08M-0.10M-0.56M-0.48M-0.47M8.44M-6.11M-6.21M-9.76M-15.77M
Operating Expenses (Quarter)
6.25M8.42M10.08M12.08M12.78M11.96M12.71M13.75M13.95M17.83M19.36M17.73M15.07M15.99M19.89M25.29M21.80M27.08M19.17M15.84M
Operating Income (Quarter)
-6.25M-8.42M-10.08M-12.08M-12.78M-11.96M-12.71M-13.75M-13.95M-17.83M-19.36M-17.73M-15.07M-15.99M-19.89M-25.29M-21.80M-27.08M-19.17M-15.84M
EBIT (Quarter)
-6.25M-8.42M-10.08M-12.08M-12.78M-11.96M-12.71M-13.75M-13.95M-17.83M-19.36M-17.73M-15.07M-15.99M-19.89M-25.29M-21.80M-27.08M-19.17M-15.84M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.09M0.26M0.35M1.10M1.44M1.43M1.23M1.39M1.45M1.28M0.94M0.62M0.44M0.34M0.34M
Other Non Operating Income (Quarter)
3.50M0.00M-3.58M0.05M-0.12M-0.04M-0.04M-0.03M0.03M-0.06M-0.08M-2.01M-0.03M
Non Operating Income (Quarter)
-0.31M1.75M1.82M1.14M1.34M1.41M1.25M0.96M0.56M0.35M0.43M6.74M
Net income details
EBT (Quarter)
5.50M-3.57M-10.08M-11.93M-17.74M-11.97M-13.19M-14.24M-13.13M-17.58M-21.29M-16.78M-14.39M-15.02M-22.47M-24.64M-21.32M-28.89M-18.88M-16.00M
Tax Provisions (Quarter)
Profit After Tax (Quarter)
-9.75M-3.41M-3.41M-6.16M-2.21M-10.40M-11.86M-13.19M-14.26M-16.08M-17.54M-16.62M-13.73M-14.60M-18.64M-24.37M-21.24M-26.72M-18.70M-9.10M
Income from Non-Controlling Interests (Quarter)
5.50M-3.57M
Income from Continuing Operations (Quarter)
5.50M-3.57M-10.08M-11.93M-17.74M-11.97M-13.19M-14.24M-13.13M-17.58M-21.29M-16.78M-14.39M-15.02M-22.47M-24.64M-21.32M-28.89M-18.88M-16.00M
Consolidated Net Income (Quarter)
5.50M-3.57M-10.08M-11.93M-17.74M-11.97M-13.19M-14.24M-13.13M-17.58M-21.29M-16.78M-14.39M-15.02M-22.47M-24.64M-21.32M-28.89M-18.88M-16.00M
Income towards Parent Company (Quarter)
5.50M-3.57M3.40M-11.93M-17.74M-11.97M11.90M-14.24M-13.13M-17.58M-21.29M-16.78M-14.39M-15.02M-22.47M-24.64M-21.32M-28.89M-18.88M-16.00M
Net Income towards Common Stockholders (Quarter)
-9.75M-3.57M-3.41M-9.06M-2.21M-11.97M11.90M-14.24M-13.13M-17.58M-21.29M-16.78M-13.73M-14.58M-22.47M-24.64M-21.24M-26.72M-18.88M-16.00M
Additional items
EPS (Basic) (Quarter)
-9.75-3.57-6.87-7.95-0.61-3.293.25-3.90-1.49-1.61-2.06-1.61-1.03-0.97-1.50-1.69-1.41-1.74-1.13-0.83
EPS (Diluted) (Quarter)
-6.87-7.95-0.61-3.293.25-3.90-1.49-1.61-2.08-1.61-1.03-0.97-1.50-1.69-1.41-1.74-1.13-0.83
Shares Outstanding (Quarter)
1.00M1.00M0.50M1.14M3.63M3.64M3.66M3.65M8.82M10.92M10.35M10.44M13.33M14.99M15.00M14.58M15.02M15.33M16.64M19.17M
Shares Outstanding (Diluted) (Quarter)
0.50M1.14M3.63M3.64M3.66M3.65M8.82M10.92M10.23M10.44M13.33M14.99M15.00M14.58M15.02M15.33M16.64M19.17M
EBITDA (Quarter)
-6.25M-8.42M-10.08M-12.08M-12.78M-11.96M-12.71M-13.75M-13.95M-17.83M-19.36M-17.73M-15.07M-15.99M-19.89M-25.29M-21.80M-27.08M-19.17M-15.84M
Interest Expenses (Quarter)
0.21M0.33M-0.15M4.96M0.10M0.74M0.85M0.28M1.19M3.37M0.28M0.71M0.48M3.87M0.29M0.14M2.25M0.06M0.50M
Tax Rate (Quarter)